153 related articles for article (PubMed ID: 22923740)
1. Depletion of glutamine enhances sodium butyrate-induced erythroid differentiation of K562 cells.
Canh Hiep N; Kinohira S; Furuyama K; Taketani S
J Biochem; 2012 Dec; 152(6):509-19. PubMed ID: 22923740
[TBL] [Abstract][Full Text] [Related]
2. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
Tahara T; Sun J; Igarashi K; Taketani S
Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
[TBL] [Abstract][Full Text] [Related]
3. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
Woessmann W; Zwanzger D; Borkhardt A
Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
[TBL] [Abstract][Full Text] [Related]
4. Possible interaction between B1 retrotransposon-containing sequences and β(major) globin gene transcriptional activation during MEL cell erythroid differentiation.
Vizirianakis IS; Tezias SS; Amanatiadou EP; Tsiftsoglou AS
Cell Biol Int; 2012 Jan; 36(1):47-55. PubMed ID: 21970403
[TBL] [Abstract][Full Text] [Related]
5. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ suppresses activin A/NF-E2 induction of erythroid gene expression through the NF-κB/c-Jun pathway.
Lee WH; Chung MH; Tsai YH; Chang JL; Huang HM
Am J Physiol Cell Physiol; 2014 Feb; 306(4):C407-14. PubMed ID: 24336657
[TBL] [Abstract][Full Text] [Related]
7. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
8. Plastrum testudinis induces γ-globin gene expression through epigenetic histone modifications within the γ-globin gene promoter via activation of the p38 MAPK signaling pathway.
Qian X; Chen J; Zhao D; Guo L; Qian X
Int J Mol Med; 2013 Jun; 31(6):1418-28. PubMed ID: 23588991
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different methods for erythroid differentiation in the K562 cell line.
Shariati L; Modaress M; Khanahmad H; Hejazi Z; Tabatabaiefar MA; Salehi M; Modarressi MH
Biotechnol Lett; 2016 Aug; 38(8):1243-50. PubMed ID: 27075690
[TBL] [Abstract][Full Text] [Related]
10. Changes in DNA methylation of erythroid-specific genes in K562 cells exposed to phenol and hydroquinone.
Li Y; Wu XR; Li XF; Suriguga ; Yu CH; Li YR; Yi ZC
Toxicology; 2013 Oct; 312():108-14. PubMed ID: 23973255
[TBL] [Abstract][Full Text] [Related]
11. Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.
Huang HM; Li YC; Chung MH
J Cell Physiol; 2010 Jun; 223(3):687-94. PubMed ID: 20162623
[TBL] [Abstract][Full Text] [Related]
12. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
Kucukkaya B; Arslan DO; Kan B
Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
[TBL] [Abstract][Full Text] [Related]
13. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus.
Shyu YC; Lee TL; Ting CY; Wen SC; Hsieh LJ; Li YC; Hwang JL; Lin CC; Shen CK
Mol Cell Biol; 2005 Dec; 25(23):10365-78. PubMed ID: 16287851
[TBL] [Abstract][Full Text] [Related]
15. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
Huang HM; Chiou HY; Chang JL
J Cell Biochem; 2006 Jul; 98(4):789-97. PubMed ID: 16440334
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
18. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
Zein S; Li W; Ramakrishnan V; Lou TF; Sivanand S; Mackie A; Pace B
Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives.
Szulawska A; Arkusinska J; Czyz M
Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070
[TBL] [Abstract][Full Text] [Related]
20. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways.
Witt O; Sand K; Pekrun A
Blood; 2000 Apr; 95(7):2391-6. PubMed ID: 10733512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
